Suppr超能文献

[第二代磺脲类制剂在糖尿病治疗中的应用]

[Second generation sulfonylurea preparations in the therapy of diabetes mellitus].

作者信息

Kliachko V R, Perelygina A A, Mazovetskiĭ A G

出版信息

Probl Endokrinol (Mosk). 1975 Sep-Oct;21(5):3-6.

PMID:132655
Abstract

The authors present the results of treatment of the patients with diabetes mellitus with hypoglycaemic preparations (sulphonylurea preparations of the second generation): glibenclamide, glibornuride and glydiazinamide. The following preparations were used: glibenclamide of Soviet make, maninil, daonyl, euglucon-5, euglucon, glutryl, glydiazinamide, glipizid. The treatment was carried out in 298 patients. The hypoglycaemic action of the active substances contained in one tablet of each of the preparation was approximately the same. Preparations of the second generation proved to be highly effective without any side-effects which required suspension of the treatment. The best results were obtained in complex therapy with the preparations of the second generation and with biguanides of prolonged action.

摘要

作者介绍了使用降血糖制剂(第二代磺酰脲类制剂)治疗糖尿病患者的结果:格列本脲、格列波脲和格列齐特。使用了以下制剂:苏联产格列本脲、美吡达、达美康、优降糖 -5、优降糖、格吕贝、格列齐特、格列吡嗪。对298例患者进行了治疗。每种制剂一片中所含活性物质的降血糖作用大致相同。第二代制剂被证明高效且无任何需要中断治疗的副作用。在第二代制剂与长效双胍类药物的联合治疗中取得了最佳效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验